Zacks Investment ResearchThu, 09 Apr 2026 16:31:15 GMTEsperion Therapeutics (ESPR) Down 10% Since Last Earnings Report: Can It Rebound?ESPR-5.20%
Zacks Investment ResearchWed, 11 Mar 2026 16:50:22 GMTESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock DownESPR-5.20%
Seeking AlphaTue, 10 Mar 2026 14:40:15 GMTEsperion Therapeutics, Inc. (ESPR) Q4 2025 Earnings Call TranscriptESPR-5.20%
Zacks Investment ResearchTue, 10 Mar 2026 12:16:10 GMTEsperion Therapeutics (ESPR) Misses Q4 Earnings EstimatesESPR-5.20%
Zacks Investment ResearchWed, 04 Mar 2026 16:40:22 GMTESPR to Boost Cardiovascular Portfolio With Corstasis Buyout for $75MESPR-5.20%
Seeking AlphaTue, 03 Mar 2026 22:22:20 GMTEsperion Therapeutics, Inc. (ESPR) M&A Call TranscriptESPR-5.20%
Zacks Investment ResearchTue, 24 Feb 2026 16:01:12 GMTEsperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy?ESPR-5.20%
